Once opened or in use, most compounded semaglutide formulations remain stable for 28 days at room temperature, though refrigeration is preferred to extend shelf life and preserve drug integrity throughout the full treatment course
3.1.2 Other PEDs This group included other substances prohibited by WADA, such as non-approved substances (BPC-157) from Section S0, other anabolic agents (clenbuterol and SARMs) from Subsection S0, S1.2, peptide hormones and their releasing factors (AOD-9604, hGH 176-191, CJC-1295, ibutamoren, ipamorelin, and growth hormone-releasing peptide) from S2.2, growth factors and growth factor modulators (thymosin-4 and its derivative TB-500) from S2.3, beta-2 agonists (salbutamol and indacaterol) from S3, metabolic modulators (meldonium, GW1516, SR9009, SR9011, and insulins) from Section S4.4, and thyroid hormones
Most side effects are mild to moderate and improve over time or with dose adjustments
2024 Feb;26(2):463-472
Which routine situations does the post say warrant contacting the care team
They enhance insulin secretion in a glucose-dependent manner, meaning insulin is released only when blood sugar levels are elevated, thereby helping to lower high glucose without significantly increasing the risk of hypoglycemia
